The Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...

The Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis ...

Early results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...

Trevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...

In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.

The CoTikiS trial’s 10-week results from the 50-week ulcerative colitis trial saw as an endoscopic improvement rate of 32% in ...

Ensho has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day treatment for ...

Novotech has signed a memorandum of understanding (MoU) with Wonju Severance Christian Hospital, aiming to boost clinical ...

Sanofi and Teva Pharmaceuticals have reported new outcomes from the Phase IIb RELIEVE UCCD trial of duvakitug.

Solid Biosciences’ gene therapy candidate for patients with DMD has elicited a 110% expression of the microdystrophin gene.

Novadip's bone graft material NVDX3 has seen all patients achieve bone fracture union in a 12-month Phase Ib/IIa ...

The Phase II portion is seeking to establish safety and efficacy of the company’s HER2 breast cancer therapy in combination ...